About
About Beijing Hotgen Biotech Co., Ltd
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers nucleic acid drugs, antibody drugs, and biotechnology health and beauty consumer products. The company also provides clinical diagnostics and product solutions, including Upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.
Visit company website
5 years, 5 months ago
Beijing Hotgen Biotech Co., Ltd is currently in a long term uptrend where the price is trading 111.9% above its 200 day moving average.
From a valuation standpoint, the stock is 37.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.2.
Beijing Hotgen Biotech Co., Ltd's total revenue sank by 23.4% to $56M since the same quarter in the previous year.
Its net income has dropped by 84.9% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 147.0% to $-18M since the same quarter in the previous year.
Based on the above factors, Beijing Hotgen Biotech Co., Ltd gets an overall score of 1/5.